PRGO News and Press, Perrigo Company plc From 07/25/19

DUBLIN , July 25, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that it will release its second quarter calendar year 2019 financial results on Thursday, August 8, 2019 . The Company will host a conference call beginning at 8 a.m. (EDT) . The conf...

This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages. Executive summary Biotechnology looks undervalued relative to its historical averages in the 3 valuat...

DUBLIN , July 8, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has completed the previously announced divestiture of its Animal Health business to PetIQ (NASDAQ: PETQ) for $185 million . Perrigo CEO and President Murray S. Kessler st...

EAGLE, Idaho, July 08, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced effective today, it has completed the previously announced acquisition of Perrigo Animal Health, ...

Perrigo's (NYSE: PRGO ) product development partner has received final approval from the FDA for its AB-rated Abbreviated New Drug Application ("ANDA") referencing Metrogel-Vaginal (metronidazole vaginal gel 0.75%). More news on: Perrigo Company plc, Healthcare stocks news, Read more...

DUBLIN , July 3, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced its product development partner received final approval from the U.S. Food and Drug Administration for its AB-rated Abbreviated New Drug Application ("ANDA") referencing Metrogel-Vaginal...

DUBLIN , July 2, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced the successful completion of its acquisition of Ranir Global Holdings LLC ("Ranir"), the leading global store brand supplier of oral self-care products, for $750 million in cash. This transactio...

Sol-Gel Technologies ( SLGL +1.6% ) has consummated its seventh collaboration agreement with Perrigo ( PRGO +1.7% ), this one aimed at the development, manufacture and commercialization of two new generic antibiotic foams. More news on: Sol-Gel Technologies Ltd., Perrigo Company plc,...

The following slide deck was published by Perrigo Company plc in conjunction with this Read more ...

DealReporter sources say Perrigo's (NYSE: PRGO ) sale talks for its RX unit have gone quiet because no bidder has met PRGO's price expectations. More news on: Perrigo Company plc, Healthcare stocks news, Read more ...